QUOTE AND NEWS
DailyFinance  Apr 1  Comment 
OPKO Health, Inc. (NYSE:OPK) today announced the appointment of Adam Logal as Senior Vice President, Chief Financial Officer. Additionally, Arie Gutman Ph.D. was appointed Chief Executive Officer of OPKO’s newly created...
StreetInsider.com  Apr 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/OPKO+Health+%28OPK%29+Names+Adam+Logal+as+CFO%2C+Arie+Gutman+as+CEO+of+APICD+Division/9337256.html for the full story.
DailyFinance  Mar 31  Comment 
OPKO Health, Inc. (NYSE:OPK) announced the availability of the 4KscoreTM Test through its CLIA-accredited OPKO Lab in Nashville, TN. The laboratory-developed test is designed to enhance the prostate biopsy decision making...
StreetInsider.com  Mar 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Opko+Health+%28OPK%29+Posts+Q4+Loss+of+4cShare/9240866.html for the full story.
SeekingAlpha  Feb 18  Comment 
By Equity Flux: Executive summary: Shares of Opko have declined around 20% in the last 3 months due to Jefferies negative commentary We believe Rayaldy and 4Kscore have a billion dollar market potential The company will be able to...
DailyFinance  Feb 13  Comment 
OPKO Health, Inc. (NYSE:OPK) announced the successful completion of the calibration confirmation phase of the 4Kscore™ test clinical validation study currently underway at 21 urology clinics in the United States. The...
SeekingAlpha  Feb 4  Comment 
By John Eastman: Back in March of 2012, I interviewed Dr. Phillip Frost of OPKO Health Inc. OPK. At the time, OPK was trading at $4.87, a 52wk range of 3.15 - 5.85, and a Market Cap of 1.44B. Moving to current day, OPK has a Market Cap of $3.25B,...
TheStreet.com  Jan 30  Comment 
By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading. NEW YORK (TheStreet) -- It is a victory for common sense. Tracking the trading behavior of company executives, directors and large shareholders in...
DailyFinance  Jan 23  Comment 
BOTHELL, WA--(Marketwired - January 23, 2014) - Biozone Pharmaceuticals, Inc. (OTCQB: BZNE) today announced that it has raised $2,750,000 from eight accredited investors including OPKO Health (NYSE MKT: OPK). The private placement offering...
SeekingAlpha  Jan 17  Comment 
By Kevin Quon: OPKO Health, Inc. (OPK) is a pharmaceutical and diagnostics company engaged in the development of several proprietary technologies. It is also the holder of several strategic investments in medical device and pharmaceutical...





You may also be interested in articles related to Opko Health Inc (OPK):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki